tetano
Editor, Senior Moderator
Isr Med Assoc J
. 2023 Sep;25(9):595-600.
Dual Oxygenation in the Treatment of Hypoxemic Respiratory Failure: A Retrospective Cohort Study
Ivan Gur[SUP] 1 [/SUP], Ronen Zalts[SUP] 2 [/SUP], Monia Azzam[SUP] 3 [/SUP], Khetam Hussein[SUP] 2 [/SUP], Ami Neuberger[SUP] 2 [/SUP], Eyal Fuchs[SUP] 2 [/SUP]
Affiliations
Background: At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many patients presented with acute hypoxemic respiratory failure, requiring ventilatory support. One treatment method was the addition of a reservoir mask to a high flow nasal cannula (HFNC) (dual oxygenation).
Objectives: To evaluate the clinical outcomes of combining reservoir mask on top of a high-flow nasal cannula.
Methods: A retrospective cohort of adult patients who were admitted due to COVID-19 during the first year of the pandemic to Rambam Health Care Campus. The primary endpoint was 30-day mortality. Secondary endpoints were incidence of invasive positive pressure ventilation initiation and admission to the intensive care unit (ICU). Patients who received positive pressure ventilation for reasons other than hypoxemic respiratory failure or who were transferred to another facility while still on HFNC were excluded.
Results: The final analysis included 333 patients; 166 were treated with dual oxygenation and 167 with HFNC only (controls). No significant differences in baseline characteristics were noted between the groups. The dual oxygenation group was slightly older (69.2 ± 14.8 years vs. 65.6 ± 15.5 years, P = 0.034). The 30-day mortality (24.1% vs. 36.5%, P = 0.013), rates of invasive positive pressure ventilation (47% vs. 59.3%, P = 0.024), and ICU admissions (41.6% vs. 52.7%, P = 0.042) were all significantly lower in the dual oxygenation group.
Conclusions: The addition of reservoir masks to HFNC may improve the oxygenation and overall prognosis in patients with severe hypoxemia due to COVID-19.
. 2023 Sep;25(9):595-600.
Dual Oxygenation in the Treatment of Hypoxemic Respiratory Failure: A Retrospective Cohort Study
Ivan Gur[SUP] 1 [/SUP], Ronen Zalts[SUP] 2 [/SUP], Monia Azzam[SUP] 3 [/SUP], Khetam Hussein[SUP] 2 [/SUP], Ami Neuberger[SUP] 2 [/SUP], Eyal Fuchs[SUP] 2 [/SUP]
Affiliations
- PMID: 37698309
Background: At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, many patients presented with acute hypoxemic respiratory failure, requiring ventilatory support. One treatment method was the addition of a reservoir mask to a high flow nasal cannula (HFNC) (dual oxygenation).
Objectives: To evaluate the clinical outcomes of combining reservoir mask on top of a high-flow nasal cannula.
Methods: A retrospective cohort of adult patients who were admitted due to COVID-19 during the first year of the pandemic to Rambam Health Care Campus. The primary endpoint was 30-day mortality. Secondary endpoints were incidence of invasive positive pressure ventilation initiation and admission to the intensive care unit (ICU). Patients who received positive pressure ventilation for reasons other than hypoxemic respiratory failure or who were transferred to another facility while still on HFNC were excluded.
Results: The final analysis included 333 patients; 166 were treated with dual oxygenation and 167 with HFNC only (controls). No significant differences in baseline characteristics were noted between the groups. The dual oxygenation group was slightly older (69.2 ± 14.8 years vs. 65.6 ± 15.5 years, P = 0.034). The 30-day mortality (24.1% vs. 36.5%, P = 0.013), rates of invasive positive pressure ventilation (47% vs. 59.3%, P = 0.024), and ICU admissions (41.6% vs. 52.7%, P = 0.042) were all significantly lower in the dual oxygenation group.
Conclusions: The addition of reservoir masks to HFNC may improve the oxygenation and overall prognosis in patients with severe hypoxemia due to COVID-19.